{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,27]],"date-time":"2026-09-27T18:00:03Z","timestamp":1790532003912,"version":"4.1.0"},"reference-count":49,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2020,6,5]],"date-time":"2020-06-05T00:00:00Z","timestamp":1591315200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2020,6,5]],"date-time":"2020-06-05T00:00:00Z","timestamp":1591315200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sig Transduct Target Ther"],"abstract":"<jats:title>Abstract<\/jats:title><jats:p>The activation of hepatic stellate cells (HSCs) participates in liver fibrosis, and emerging evidences indicate that microRNAs (miRNAs) are abnormally expressed during HSC activation. However, the potential roles of miRNAs in liver fibrosis still remain elusive. Therefore, this study aimed to investigate the role of miR-199a-3p in liver fibrosis and its underlying mechanism. We found that miR-199a-3p expression was dramatically upregulated during HSC activation in vitro, and during liver fibrogenesis in CCl<jats:sub>4<\/jats:sub>-treated rats, and its liver expression was increased in the patients with cirrhosis. By the luciferase assay and RT-qPCR, we revealed that the expression of miR-199a-3p in HSCs was driven by the transcription factor Twist1 which could be further induced by TGF-\u03b2 treatment. Functional studies showed that inhibition of miR-199a-3p in both human LX2 cells and rat HSCs significantly decreased the expression of fibrotic markers, such as fibronectin and connective tissue growth factor (CTGF), whereas the forced expression of miR-199a-3p exhibited opposite effects, demonstrating the role of miR-199a-3p in promoting HSC activation. Mechanistically, miR-199a-3p plays an important role in TGF-\u03b2 signalling pathway activation through targeting CAV2 that negatively regulates the expression of transforming growth factor-beta receptor type I (TGF\u03b2RI). Importantly, administration of antagomiR-199a-3p in the CCl<jats:sub>4<\/jats:sub>-treated mice significantly ameliorated hepatic fibrosis. In conclusion, Twist1-induced miR-199a-3p mediates the activation of HSCs by suppressing CAV2 expression and subsequently increasing TGF\u03b2RI expression to promote TGF-\u03b2 pathway. Our findings highlight the therapeutic potential of miR-199a-3p for hepatic fibrosis.<\/jats:p>","DOI":"10.1038\/s41392-020-0169-z","type":"journal-article","created":{"date-parts":[[2020,6,4]],"date-time":"2020-06-04T23:04:14Z","timestamp":1591311854000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":57,"title":["Twist1-induced miR-199a-3p promotes liver fibrosis by suppressing caveolin-2 and activating TGF-\u03b2 pathway"],"prefix":"10.1038","volume":"5","author":[{"given":"Xiaoxue","family":"Yang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Liping","family":"Ma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rong","family":"Wei","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3296-6753","authenticated-orcid":false,"given":"Tinghong","family":"Ye","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"JianKang","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maoyao","family":"Wen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ruoting","family":"Men","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rami I.","family":"Aqeilan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1181-3467","authenticated-orcid":false,"given":"Yong","family":"Peng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Li","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2020,6,5]]},"reference":[{"key":"169_CR1","doi-asserted-by":"publisher","first-page":"2099","DOI":"10.1002\/hep.27406","volume":"60","author":"FS Wang","year":"2014","unstructured":"Wang, F. S., Fan, J. G., Zhang, Z., Gao, B. & Wang, H. Y. The global burden of liver disease: the major impact of China. Hepatology 60, 2099\u20132108 (2014).","journal-title":"Hepatology"},{"key":"169_CR2","doi-asserted-by":"publisher","first-page":"181","DOI":"10.1038\/nri3623","volume":"14","author":"A Pellicoro","year":"2014","unstructured":"Pellicoro, A., Ramachandran, P., Iredale, J. P. & Fallowfield, J. A. Liver fibrosis and repair: immune regulation of wound healing in a solid organ. Nat. Rev. Immunol. 14, 181\u2013194 (2014).","journal-title":"Nat. Rev. Immunol."},{"key":"169_CR3","doi-asserted-by":"publisher","first-page":"830","DOI":"10.1136\/gutjnl-2014-306842","volume":"64","author":"YA Lee","year":"2015","unstructured":"Lee, Y. A., Wallace, M. C. & Friedman, S. L. Pathobiology of liver fibrosis: a translational success story. Gut 64, 830\u2013841 (2015).","journal-title":"Gut"},{"key":"169_CR4","doi-asserted-by":"publisher","first-page":"125","DOI":"10.1152\/physrev.00013.2007","volume":"88","author":"SL Friedman","year":"2008","unstructured":"Friedman, S. L. Hepatic stellate cells: protean, multifunctional, and enigmatic cells of the liver. Physiol. Rev. 88, 125\u2013172 (2008).","journal-title":"Physiol. Rev."},{"key":"169_CR5","doi-asserted-by":"publisher","first-page":"84","DOI":"10.1016\/j.preteyeres.2016.09.005","volume":"56","author":"X Gu","year":"2017","unstructured":"Gu, X., Reagan, A. M., McClellan, M. E. & Elliott, M. H. Caveolins and caveolae in ocular physiology and pathophysiology. Prog. Retin. Eye. Res. 56, 84\u2013106 (2017).","journal-title":"Prog. Retin. Eye. Res."},{"key":"169_CR6","doi-asserted-by":"publisher","first-page":"889","DOI":"10.1016\/j.molmed.2016.08.007","volume":"22","author":"MA Fernandez-Rojo","year":"2016","unstructured":"Fernandez-Rojo, M. A. & Ramm, G. A. Caveolin-1 function in liver physiology and disease. Trends Mol. Med. 22, 889\u2013904 (2016).","journal-title":"Trends Mol. Med."},{"key":"169_CR7","doi-asserted-by":"publisher","first-page":"681","DOI":"10.1016\/j.cub.2011.03.030","volume":"21","author":"M Bosch","year":"2011","unstructured":"Bosch, M. et al. Caveolin-1 deficiency causes cholesterol-dependent mitochondrial dysfunction and apoptotic susceptibility. Curr. Biol. 21, 681\u2013686 (2011).","journal-title":"Curr. Biol."},{"key":"169_CR8","doi-asserted-by":"publisher","first-page":"687","DOI":"10.1002\/hep.27162","volume":"60","author":"L Gao","year":"2014","unstructured":"Gao, L. et al. Caveolin-1 is essential for protecting against binge drinking-induced liver damage through inhibiting reactive nitrogen species. Hepatology 60, 687\u2013699 (2014).","journal-title":"Hepatology"},{"key":"169_CR9","doi-asserted-by":"publisher","first-page":"238","DOI":"10.1016\/j.celrep.2013.06.017","volume":"4","author":"MA Fernandez-Rojo","year":"2013","unstructured":"Fernandez-Rojo, M. A. et al. Caveolin-1 is necessary for hepatic oxidative lipid metabolism: evidence for crosstalk between caveolin-1 and bile acid signalling. Cell Rep. 4, 238\u2013247 (2013).","journal-title":"Cell Rep."},{"key":"169_CR10","doi-asserted-by":"publisher","first-page":"1477","DOI":"10.1016\/j.hep.2003.09.011","volume":"38","author":"M Moreno","year":"2003","unstructured":"Moreno, M. et al. Hepatic overexpression of caveolins increases bile salt secretion in mice. Hepatology 38, 1477\u20131488 (2003).","journal-title":"Hepatology"},{"key":"169_CR11","doi-asserted-by":"publisher","first-page":"508","DOI":"10.1016\/j.redox.2017.07.011","volume":"13","author":"X Luo","year":"2017","unstructured":"Luo, X. et al. Caveolin 1-related autophagy initiated by aldosterone-induced oxidation promotes liver sinusoidal endothelial cells defenestration. Redox Biol. 13, 508\u2013521 (2017).","journal-title":"Redox Biol."},{"key":"169_CR12","doi-asserted-by":"publisher","first-page":"7242","DOI":"10.1158\/0008-5472.CAN-16-1031","volume":"76","author":"X Mao","year":"2016","unstructured":"Mao, X. et al. Mechanisms through which hypoxia-induced caveolin-1 drives tumorigenesis and metastasis in hepatocellular carcinoma. Cancer Res. 76, 7242\u20137253 (2016).","journal-title":"Cancer Res."},{"key":"169_CR13","doi-asserted-by":"publisher","first-page":"15004","DOI":"10.1038\/sigtrans.2015.4","volume":"1","author":"Y Peng","year":"2016","unstructured":"Peng, Y. & Croce, C. M. The role of MicroRNAs in human cancer. Signal Transduct. Target Ther. 1, 15004 (2016).","journal-title":"Signal Transduct. Target Ther."},{"key":"169_CR14","doi-asserted-by":"publisher","DOI":"10.1038\/ncomms10993","volume":"7","author":"J Hyun","year":"2016","unstructured":"Hyun, J. et al. MicroRNA-378 limits activation of hepatic stellate cells and liver fibrosis by suppressing Gli3 expression. Nat. Commun. 7, 10993 (2016).","journal-title":"Nat. Commun."},{"key":"169_CR15","doi-asserted-by":"publisher","DOI":"10.1038\/s41419-018-0752-1","volume":"9","author":"L Ma","year":"2018","unstructured":"Ma, L. et al. MicroRNA-214 promotes hepatic stellate cell activation and liver fibrosis by suppressing Sufu expression. Cell Death Dis. 9, 718 (2018).","journal-title":"Cell Death Dis."},{"key":"169_CR16","doi-asserted-by":"publisher","first-page":"522","DOI":"10.1016\/j.jhep.2012.11.011","volume":"58","author":"J Li","year":"2013","unstructured":"Li, J. et al. miR-122 regulates collagen production via targeting hepatic stellate cells and suppressing P4HA1 expression. J. Hepatol. 58, 522\u2013528 (2013).","journal-title":"J. Hepatol."},{"key":"169_CR17","doi-asserted-by":"publisher","first-page":"736","DOI":"10.1016\/j.jhep.2012.11.022","volume":"58","author":"C Roderburg","year":"2013","unstructured":"Roderburg, C. et al. miR-133a mediates TGF-beta-dependent derepression of collagen synthesis in hepatic stellate cells during liver fibrosis. J. Hepatol. 58, 736\u2013742 (2013).","journal-title":"J. Hepatol."},{"key":"169_CR18","doi-asserted-by":"publisher","first-page":"46","DOI":"10.1002\/path.4373","volume":"234","author":"X Tu","year":"2014","unstructured":"Tu, X. et al. MicroRNA-101 suppresses liver fibrosis by targeting the TGFbeta signalling pathway. J. Pathol. 234, 46\u201359 (2014).","journal-title":"J. Pathol."},{"key":"169_CR19","doi-asserted-by":"publisher","first-page":"1600","DOI":"10.1136\/gutjnl-2011-300717","volume":"61","author":"T Ogawa","year":"2012","unstructured":"Ogawa, T. et al. MicroRNA-221\/222 upregulation indicates the activation of stellate cells and the progression of liver fibrosis. Gut 61, 1600\u20131609 (2012).","journal-title":"Gut"},{"key":"169_CR20","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1007\/s11010-014-2199-8","volume":"398","author":"J Zheng","year":"2015","unstructured":"Zheng, J. et al. Hepatic stellate cell is activated by microRNA-181b via PTEN\/Akt pathway. Mol. Cell Biochem. 398, 1\u20139 (2015).","journal-title":"Mol. Cell Biochem."},{"key":"169_CR21","doi-asserted-by":"publisher","first-page":"300","DOI":"10.1002\/hep.25613","volume":"56","author":"AM Lakner","year":"2012","unstructured":"Lakner, A. M. et al. Inhibitory effects of microRNA 19b in hepatic stellate cell-mediated fibrogenesis. Hepatology 56, 300\u2013310 (2012).","journal-title":"Hepatology"},{"key":"169_CR22","doi-asserted-by":"publisher","first-page":"d808","DOI":"10.2741\/reeves","volume":"7","author":"HL Reeves","year":"2002","unstructured":"Reeves, H. L. & Friedman, S. L. Activation of hepatic stellate cells\u2014a key issue in liver fibrosis. Front. Biosci. 7, d808\u2013d826 (2002).","journal-title":"Front. Biosci."},{"key":"169_CR23","doi-asserted-by":"publisher","first-page":"2826","DOI":"10.1242\/jcs.077529","volume":"124","author":"T Shatseva","year":"2011","unstructured":"Shatseva, T., Lee, D. Y., Deng, Z. & Yang, B. B. MicroRNA miR-199a-3p regulates cell proliferation and survival by targeting caveolin-2. J. Cell Sci. 124, 2826\u20132836 (2011).","journal-title":"J. Cell Sci."},{"key":"169_CR24","doi-asserted-by":"publisher","first-page":"6452","DOI":"10.1158\/0008-5472.CAN-14-1408","volume":"74","author":"Y Liu","year":"2014","unstructured":"Liu, Y., Jang, S., Xie, L. & Sowa, G. Host deficiency in caveolin-2 inhibits lung carcinoma tumour growth by impairing tumour angiogenesis. Cancer Res. 74, 6452\u20136462 (2014).","journal-title":"Cancer Res."},{"key":"169_CR25","doi-asserted-by":"publisher","first-page":"284","DOI":"10.1136\/gut.2005.088690","volume":"56","author":"Y Inagaki","year":"2007","unstructured":"Inagaki, Y. & Okazaki, I. Emerging insights into transforming growth factor beta Smad signal in hepatic fibrogenesis. Gut 56, 284\u2013292 (2007).","journal-title":"Gut"},{"key":"169_CR26","doi-asserted-by":"publisher","first-page":"2219","DOI":"10.1111\/febs.13665","volume":"283","author":"I Fabregat","year":"2016","unstructured":"Fabregat, I. et al. TGF-beta signalling and liver disease. Febs. J. 283, 2219\u20132232 (2016).","journal-title":"Febs. J."},{"key":"169_CR27","doi-asserted-by":"publisher","first-page":"58","DOI":"10.1038\/cr.2008.315","volume":"19","author":"YG Chen","year":"2009","unstructured":"Chen, Y. G. Endocytic regulation of TGF-beta signalling. Cell Res. 19, 58\u201370 (2009).","journal-title":"Cell Res."},{"key":"169_CR28","doi-asserted-by":"publisher","first-page":"123","DOI":"10.1093\/nar\/gkn920","volume":"37","author":"YB Lee","year":"2009","unstructured":"Lee, Y. B. et al. Twist-1 regulates the miR-199a\/214 cluster during development. Nucleic Acids Res. 37, 123\u2013128 (2009).","journal-title":"Nucleic Acids Res."},{"key":"169_CR29","doi-asserted-by":"publisher","first-page":"1729","DOI":"10.3390\/ijms19061729","volume":"19","author":"J Lu","year":"2018","unstructured":"Lu, J., Zhang, J., Wang, Y. & Sun, Q. Caveolin-1 scaffolding domain peptides alleviate liver fibrosis by inhibiting TGF-beta1\/Smad signalling in mice. Int J. Mol. Sci. 19, 1729 (2018).","journal-title":"Int J. Mol. Sci."},{"key":"169_CR30","doi-asserted-by":"publisher","first-page":"394","DOI":"10.3322\/caac.21492","volume":"68","author":"F Bray","year":"2018","unstructured":"Bray, F. et al. Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J. Clin. 68, 394\u2013424 (2018).","journal-title":"CA Cancer J. Clin."},{"key":"169_CR31","doi-asserted-by":"publisher","DOI":"10.1038\/ncomms3823","volume":"4","author":"I Mederacke","year":"2013","unstructured":"Mederacke, I. et al. Fate tracing reveals hepatic stellate cells as dominant contributors to liver fibrosis independent of its aetiology. Nat. Commun. 4, 2823 (2013).","journal-title":"Nat. Commun."},{"key":"169_CR32","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pgen.1003291","volume":"9","author":"CL Lino Cardenas","year":"2013","unstructured":"Lino Cardenas, C. L. et al. miR-199a-5p Is upregulated during fibrogenic response to tissue injury and mediates TGFbeta-induced lung fibroblast activation by targeting caveolin-1. PLoS Genet. 9, e1003291 (2013).","journal-title":"PLoS Genet."},{"key":"169_CR33","doi-asserted-by":"publisher","first-page":"2459","DOI":"10.1681\/ASN.2016060663","volume":"28","author":"M Che","year":"2017","unstructured":"Che, M. et al. The microRNA-199a\/214 cluster targets E-cadherin and claudin-2 and promotes high glucose-induced peritoneal fibrosis. J. Am. Soc. Nephrol. 28, 2459\u20132471 (2017).","journal-title":"J. Am. Soc. Nephrol."},{"key":"169_CR34","doi-asserted-by":"publisher","first-page":"2921","DOI":"10.1016\/j.ajpath.2016.07.011","volume":"186","author":"L Chen","year":"2016","unstructured":"Chen, L., Chen, R., Velazquez, V. M. & Brigstock, D. R. Fibrogenic signaling is suppressed in hepatic stellate cells through targeting of connective tissue growth factor (CCN2) by cellular or exosomal MicroRNA-199a-5p. Am. J. Pathol. 186, 2921\u20132933 (2016).","journal-title":"Am. J. Pathol."},{"key":"169_CR35","doi-asserted-by":"publisher","first-page":"1285","DOI":"10.1002\/hep.25975","volume":"57","author":"SL Chen","year":"2013","unstructured":"Chen, S. L., Zheng, M. H., Yang, T., Song, M. & Chen, Y. P. Disparate profiles of dys-regulated miRNAs in activated hepatic stellate cells. Hepatology 57, 1285\u20131286 (2013).","journal-title":"Hepatology"},{"key":"169_CR36","doi-asserted-by":"publisher","first-page":"1206","DOI":"10.1053\/j.gastro.2012.01.007","volume":"142","author":"CG Lee","year":"2012","unstructured":"Lee, C. G. et al. Farnesoid X receptor protects hepatocytes from injury by repressing miR-199a-3p, which increases levels of LKB1. Gastroenterology 142, 1206\u20131217. e1207 (2012).","journal-title":"Gastroenterology"},{"key":"169_CR37","doi-asserted-by":"publisher","first-page":"209","DOI":"10.1002\/hep.23922","volume":"53","author":"C Roderburg","year":"2011","unstructured":"Roderburg, C. et al. Micro-RNA profiling reveals a role for miR-29 in human and murine liver fibrosis. Hepatology 53, 209\u2013218 (2011).","journal-title":"Hepatology"},{"key":"169_CR38","doi-asserted-by":"publisher","first-page":"S54","DOI":"10.1002\/hep.21060","volume":"43","author":"V Racanelli","year":"2006","unstructured":"Racanelli, V. & Rehermann, B. The liver as an immunological organ. Hepatology 43, S54\u2013S62 (2006).","journal-title":"Hepatology"},{"key":"169_CR39","doi-asserted-by":"publisher","first-page":"3197","DOI":"10.1242\/jcs.165233","volume":"128","author":"JF Aranda","year":"2015","unstructured":"Aranda, J. F., Canfran-Duque, A., Goedeke, L., Suarez, Y. & Fernandez-Hernando, C. The miR-199-dynamin regulatory axis controls receptor-mediated endocytosis. J. Cell Sci. 128, 3197\u20133209 (2015).","journal-title":"J. Cell Sci."},{"key":"169_CR40","doi-asserted-by":"publisher","first-page":"3545","DOI":"10.1038\/onc.2010.111","volume":"29","author":"G Yin","year":"2010","unstructured":"Yin, G. et al. TWISTing stemness, inflammation and proliferation of epithelial ovarian cancer cells through MIR199A2\/214. Oncogene 29, 3545\u20133553 (2010).","journal-title":"Oncogene"},{"key":"169_CR41","doi-asserted-by":"publisher","first-page":"1680","DOI":"10.1158\/0008-5472.CAN-10-2345","volume":"71","author":"K Sakurai","year":"2011","unstructured":"Sakurai, K. et al. MicroRNAs miR-199a-5p and -3p target the Brm subunit of SWI\/SNF to generate a double-negative feedback loop in a variety of human cancers. Cancer Res. 71, 1680\u20131689 (2011).","journal-title":"Cancer Res."},{"key":"169_CR42","doi-asserted-by":"publisher","first-page":"707","DOI":"10.1053\/j.gastro.2015.11.002","volume":"150","author":"DB Uthaya Kumar","year":"2016","unstructured":"Uthaya Kumar, D. B. et al. TLR4 signalling via NANOG cooperates with STAT3 to activate twist1 and promote formation of tumour-initiating stem-like cells in livers of mice. Gastroenterology 150, 707\u2013719 (2016).","journal-title":"Gastroenterology"},{"key":"169_CR43","doi-asserted-by":"publisher","first-page":"1349","DOI":"10.1002\/hep.26467","volume":"58","author":"YP Wang","year":"2013","unstructured":"Wang, Y. P. et al. Lipocalin-2 negatively modulates the epithelial-to-mesenchymal transition in hepatocellular carcinoma through the epidermal growth factor (TGF-beta1)\/Lcn2\/Twist1 pathway. Hepatology 58, 1349\u20131361 (2013).","journal-title":"Hepatology"},{"key":"169_CR44","doi-asserted-by":"publisher","first-page":"654","DOI":"10.1016\/j.cell.2013.03.043","volume":"153","author":"A Helwak","year":"2013","unstructured":"Helwak, A., Kudla, G., Dudnakova, T. & Tollervey, D. Mapping the human miRNA interactome by CLASH reveals frequent noncanonical binding. Cell 153, 654\u2013665 (2013).","journal-title":"Cell"},{"key":"169_CR45","doi-asserted-by":"publisher","DOI":"10.1038\/ncomms11012","volume":"7","author":"S Yin","year":"2016","unstructured":"Yin, S. et al. Differential TGFbeta pathway targeting by miR-122 in humans and mice affects liver cancer metastasis. Nat. Commun. 7, 11012 (2016).","journal-title":"Nat. Commun."},{"key":"169_CR46","doi-asserted-by":"publisher","first-page":"3710","DOI":"10.3748\/wjg.v11.i24.3710","volume":"11","author":"H Yokomori","year":"2005","unstructured":"Yokomori, H. et al. High expressions of caveolins on the proliferating bile ductules in primary biliary cirrhosis. World J. Gastroenterol. 11, 3710\u20133713 (2005).","journal-title":"World J. Gastroenterol."},{"key":"169_CR47","doi-asserted-by":"publisher","first-page":"1365","DOI":"10.1016\/S1097-2765(00)00134-9","volume":"6","author":"P Kavsak","year":"2000","unstructured":"Kavsak, P. et al. Smad7 binds to Smurf2 to form an E3 ubiquitin ligase that targets the TGF\u03b2 receptor for degradation. Mol. Cell 6, 1365\u20131375 (2000).","journal-title":"Mol. Cell"},{"key":"169_CR48","doi-asserted-by":"publisher","first-page":"6727","DOI":"10.1074\/jbc.M008340200","volume":"276","author":"B Razani","year":"2001","unstructured":"Razani, B. et al. Caveolin-1 regulates transforming growth factor (TGF)-beta\/SMAD signalling through an interaction with the TGF-beta type I receptor. J. Biol. Chem. 276, 6727\u20136738 (2001).","journal-title":"J. Biol. Chem."},{"key":"169_CR49","first-page":"99","volume":"117","author":"R Weiskirchen","year":"2005","unstructured":"Weiskirchen, R. & Gressner, A. M. Isolation and culture of hepatic stellate cells. Methods Mol. Med. 117, 99\u2013113 (2005).","journal-title":"Methods Mol. Med."}],"container-title":["Signal Transduction and Targeted Therapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41392-020-0169-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41392-020-0169-z","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41392-020-0169-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,12,5]],"date-time":"2022-12-05T13:46:03Z","timestamp":1670247963000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41392-020-0169-z"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,6,5]]},"references-count":49,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2020,12]]}},"alternative-id":["169"],"URL":"https:\/\/doi.org\/10.1038\/s41392-020-0169-z","relation":{},"ISSN":["2059-3635"],"issn-type":[{"value":"2059-3635","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,6,5]]},"assertion":[{"value":"27 August 2019","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 January 2020","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 January 2020","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"5 June 2020","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"75"}}